Anti-Diabetic Medication

Anti-Diabetic Medications work by either lowering down blood glucose level or by increasing sensitivity to insulin. Type 1 Diabetes is caused by lack of insulin hence, insulin has to be administered subcutaneously. Type 2 Diabetes is treated by oral hypoglycemic agents which act either by (a) increasing the amount of insulin secreted by the pancreas, (b) increasing the sensitivity of target organs to insulin or (c) decreasing the rate at which glucose is absorbed from the gastrointestinal tract.

  • Human Recombinant Insulin
  • Biguanides
  • Sulphonylureas
  • Meglitinides
  • Thiazolidinediones
  • Alpha-Glucosidase Inhibitors
  • Incretin Agonists

Related Conference of Anti-Diabetic Medication

February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Aix-en-Provence, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Aix-en-Provence, France

Anti-Diabetic Medication Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in